Delivery Order SPE2DB22D2206-SPE2DB24FDU01
- Not listed
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award, valued at $1,013.63, is a Delivery Order contract with a firm fixed price pricing type, issued by the Defense Logistics Agency (DLA) on July 6, 2023. The contract is for the delivery of IBSRELA 50 MG TABLET, a pharmaceutical product, with a completion date of July 7, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DX24F5M9B) with a firm fixed price of $7,315.47 and a completion date of May 1, 2024. The award is made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of IBSRELA 50 MG TABLET. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $13,242.25 Delivery Order contract is for the provision of IBSRELA 50 MG TABLET in 60-count units. The contract is a Firm Fixed Price arrangement with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $20,388.82 firm fixed price delivery order is for the supply of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product, to support military treatment programs and facilities. The award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor,...
- This federal contract award, valued at $13,341.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBSRELA 50 MG TABLET, a pharmaceutical product, with a completion date of May 8, 2025. The contract is a Firm Fixed Price Delivery Order, and it is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,424.60. The contract is for the supply of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order worth $7,990.09 for the pharmaceutical product IBSRELA 50 MG TABLET UU 60S. The award was made by the Defense Logistics Agency (DLA), which is part of the U.S. Department of Defense and serves as a critical supplier of medical and pharmaceutical products to federal agencies. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of IBSRELA 50 MG TABLET UU 60S. The contract, with a ceiling value of $6,486.85, is a delivery order type with firm fixed pricing. The period of performance is from the award date of October 11, 2024 through October 15, 2024. This contract award is not designated as a set-aside. AmerisourceBergen has a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $72,986.26 firm fixed-price contract is for the delivery of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract has a completion date of June 18, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,876.44 and a completion date of June 12, 2025. It is not a set-aside contract. The contract provides for the delivery of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FDU01Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $35,409.42 firm-fixed-price delivery order is for the pharmaceutical product IBSRELA 50 MG TABLET UU 60S. The contract has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.4k | 10/18/23 |